Preferred Name | Cobicistat | |
Synonyms |
|
|
ID |
http://www.phoc.org.cn/pmo/class/PMO_00016337 |
|
Database_Cross_Reference |
MTH:NOCODE NDDF:014623 SNOMEDCT_US:714771003 MMSL:d07897 ATC:V03AX03 MSH:D000069547 MEDCIN:344274 NCI:C97360 NDFRT:N0000191982 MMSL:28748 SNOMEDCT_US:710109003 RXNORM:1306284 VANDF:4031664 DRUGBANK:DB09065 NCI_FDA:LW2E03M5PG NDFRT:N0000185511 MTHSPL:LW2E03M5PG |
|
label |
Cobicistat |
|
MCID |
MC00829729 |
|
PMOID |
PMO:00016337 |
|
prefixIRI |
pmo:PMO_00016337 |
|
prefLabel |
Cobicistat |
|
Synonym |
antiviral pharmacokinetic enhancers cobicistat Cobicistat [Chemical/Ingredient] 2,7,10,12-Tetraazatridecanoic acid, 12-methyl-13-(2-(1-methylethyl)-4-thiazolyl)-9-(2-(4-morpholinyl)ethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3R,6R,9S)- Cobicistat (substance) COBICISTAT Cobicistat (product) cobicistat cobicistat (medication) 1,3-thiazol-5-ylmethyl [(2R,5R)-5-{[(2S)-2-({[(2-isopropyl-1,3-thiazol-4-yl)methyl](methyl)carbamoyl}amino)-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphenylhexan-2-yl]carbamate |
|
Tree Number |
T6.16.3.8.2.22 T6.2.31.29.22 T6.4.14.5.2.2.15 T6.14.10.29.22 T6.2.28.1.10.15 |
|
subClassOf |